Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based study.
Reimar Wernich ThomsenL M BaggesenM SøgaardL PedersenH NørrelundE S BuhlC L HaaseS P JohnsenPublished in: Diabetic medicine : a journal of the British Diabetic Association (2016)
Among people with Type 2 diabetes, 22 and 38% reached a target HbA1c < 53 mmol/mol (< 7%) or < 58 mmol/mol (< 7.5%), respectively, after intensification of their basal insulin therapy. Compared with premixed insulin, target attainment was similar with bolus insulin and higher with GLP-1 receptor agonists.